Yahoo Web Search

Search results

1. Kymera Therapeutics, Inc.

   NasdaqGM: KYMR

   33.66

   Add to watchlist

   Sign in to add to watchlist

   Sign In

   -0.39 (-1.15%)

   As of Tue. May 28, 2024 3:52 PM EDT · Nasdaq Real Time Price (USD) · Market open

   Full chart

   • 1D
   • 5D
   • 1M
   • 6M
   • YTD
   • 1Y
   • MAX

   • Open	34.43
     High	34.43
     Low	33.05

   • Mkt Cap	2.07B
     P/E (TTM)	N/A
     Div & Yield	N/A & N/A

   • Prev. Close	34.05
     52 Wk. Low	9.60
     52 Wk. High	45.31

   More about KYMR

   Related stocks

   • NRIX
     Nurix Therapeutics, Inc.
     NRIX
     15.74
     +3.76%
   • RLAY
     Relay Therapeutics, Inc.
     RLAY
     6.72
     -1.54%
   • CCCC
     C4 Therapeutics, Inc.
     CCCC
     5.43
     -1.00%
   • RVMD
     Revolution Medicines, Inc.
     RVMD
     38.01
     +0.14%
   • ITOS
     iTeos Therapeutics, Inc.
     ITOS
     17.08
     -3.42%

   More on Yahoo Finance

2. finance.yahoo.com › quote › KYMRKymera Therapeutics, Inc. (KYMR) Stock Price, News, Quote ...

   finance.yahoo.com › quote › KYMR

   • Cached

   42.81. -3.30%. Find the latest Kymera Therapeutics, Inc. (KYMR) stock quote, history, news and other vital information to help you with your stock trading and investing.

3. investors.kymeratx.comKymera Overview | Kymera Therapeutics, Inc.

   investors.kymeratx.com

   • Cached

   May 2, 2024 · Kymera is a biopharmaceutical company developing small molecule drugs that degrade disease-causing proteins. Find stock information, events, presentations, press releases, filings, and more on this website.

4. Images

   • 
   • 
   • 
   • 

   View all

5. www.google.com › finance › quoteKymera Therapeutics Inc (KYMR) Stock Price & News - Google ...

   www.google.com › finance › quote

   • Cached

   Get the latest Kymera Therapeutics Inc (KYMR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.

6. www.kymeratx.comRevolutionary Medicines Catalyzed by Protein Degradation ...

   www.kymeratx.com

   • Cached

   Kymera is a biotech company that develops medicines using targeted protein degradation, a novel modality that can address a wide range of diseases. Learn more about Kymera's pipeline, team, and vision to reinvent medicine.

7. www.marketwatch.com › investing › stockKYMR Stock Price | Kymera Therapeutics Inc. Stock Quote (U.S ...

   www.marketwatch.com › investing › stock

   May 2, 2024 · KYMR is the ticker symbol for Kymera Therapeutics Inc., a biotech company developing protein degradation therapies. Get the latest stock price, earnings, analyst ratings, news and more on MarketWatch.

   • 1 Month: 15.43%
   • 5 Day: 3.22%

   • 3 Month: 25.26%
   • YTD: 35.25%

8. investors.kymeratx.com › news-events › press-releasesPress Releases | Kymera Therapeutics, Inc.

   investors.kymeratx.com › news-events › press-releases

   • Cached

   Kymera Therapeutics is a biopharmaceutical company developing small molecule medicines using targeted protein degradation. Read the latest news on its immunology and oncology programs, financial results, and public offerings.

9. seekingalpha.com › symbol › KYMRKymera Therapeutics, Inc. (KYMR) Stock Price, Quote, News ...

   seekingalpha.com › symbol › KYMR

   • Cached

   Aug 6, 2020 · A high-level overview of Kymera Therapeutics, Inc. (KYMR) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.